vs
Side-by-side financial comparison of Climb Global Solutions, Inc. (CLMB) and Enhabit, Inc. (EHAB). Click either name above to swap in a different company.
Enhabit, Inc. is the larger business by last-quarter revenue ($270.4M vs $182.4M, roughly 1.5× Climb Global Solutions, Inc.). Climb Global Solutions, Inc. runs the higher net margin — 1.8% vs -14.3%, a 16.1% gap on every dollar of revenue. On growth, Climb Global Solutions, Inc. posted the faster year-over-year revenue change (32.1% vs 4.7%). Over the past eight quarters, Climb Global Solutions, Inc.'s revenue compounded faster (40.7% CAGR vs 1.5%).
Univar Solutions Inc. is a global chemical and ingredients distributor and provider of value-added services.
Enhabit, Inc., is a Dallas, Texas-based provider of home health and hospice services. The company operates 255 home health and 110 hospice locations in 34 states with a concentration in Texas, Alabama, Florida, Georgia, Oklahoma and Mississippi. Enhabit is the fourth-largest provider of home health services in the United States and is a leading provider of hospice services. The company was formed in 2022 when Encompass Health spun off its home health and hospice business.
CLMB vs EHAB — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $182.4M | $270.4M |
| Net Profit | $3.3M | $-38.7M |
| Gross Margin | 14.5% | — |
| Operating Margin | 2.1% | -12.3% |
| Net Margin | 1.8% | -14.3% |
| Revenue YoY | 32.1% | 4.7% |
| Net Profit YoY | -9.5% | 15.9% |
| EPS (diluted) | $0.18 | $-0.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $182.4M | — | ||
| Q4 25 | $193.8M | $270.4M | ||
| Q3 25 | $161.3M | $263.6M | ||
| Q2 25 | $159.3M | $266.1M | ||
| Q1 25 | $138.0M | $259.9M | ||
| Q4 24 | $161.8M | $258.2M | ||
| Q3 24 | $119.3M | $253.6M | ||
| Q2 24 | $92.1M | $260.6M |
| Q1 26 | $3.3M | — | ||
| Q4 25 | $7.0M | $-38.7M | ||
| Q3 25 | $4.7M | $11.1M | ||
| Q2 25 | $6.0M | $5.2M | ||
| Q1 25 | $3.7M | $17.8M | ||
| Q4 24 | $7.0M | $-46.0M | ||
| Q3 24 | $5.5M | $-110.2M | ||
| Q2 24 | $3.4M | $-200.0K |
| Q1 26 | 14.5% | — | ||
| Q4 25 | 15.4% | — | ||
| Q3 25 | 15.9% | — | ||
| Q2 25 | 16.5% | — | ||
| Q1 25 | 16.9% | — | ||
| Q4 24 | 19.3% | — | ||
| Q3 24 | 20.3% | — | ||
| Q2 24 | 20.2% | — |
| Q1 26 | 2.1% | — | ||
| Q4 25 | 4.9% | -12.3% | ||
| Q3 25 | 4.3% | 6.4% | ||
| Q2 25 | 5.0% | 6.3% | ||
| Q1 25 | 3.5% | 6.1% | ||
| Q4 24 | 7.2% | -16.0% | ||
| Q3 24 | 7.1% | -38.6% | ||
| Q2 24 | 4.6% | 4.3% |
| Q1 26 | 1.8% | — | ||
| Q4 25 | 3.6% | -14.3% | ||
| Q3 25 | 2.9% | 4.2% | ||
| Q2 25 | 3.7% | 2.0% | ||
| Q1 25 | 2.7% | 6.8% | ||
| Q4 24 | 4.3% | -17.8% | ||
| Q3 24 | 4.6% | -43.5% | ||
| Q2 24 | 3.7% | -0.1% |
| Q1 26 | $0.18 | — | ||
| Q4 25 | $1.51 | $-0.76 | ||
| Q3 25 | $1.02 | $0.22 | ||
| Q2 25 | $1.30 | $0.10 | ||
| Q1 25 | $0.81 | $0.35 | ||
| Q4 24 | $1.52 | $-0.92 | ||
| Q3 24 | $1.19 | $-2.20 | ||
| Q2 24 | $0.75 | $0.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $41.8M | $43.6M |
| Total DebtLower is stronger | — | $426.0M |
| Stockholders' EquityBook value | $118.4M | $534.0M |
| Total Assets | $458.8M | $1.2B |
| Debt / EquityLower = less leverage | — | 0.80× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $41.8M | — | ||
| Q4 25 | $36.6M | $43.6M | ||
| Q3 25 | $49.8M | $56.9M | ||
| Q2 25 | $28.6M | $37.1M | ||
| Q1 25 | $32.5M | $39.5M | ||
| Q4 24 | $29.8M | $28.4M | ||
| Q3 24 | $22.1M | $45.7M | ||
| Q2 24 | $48.4M | $28.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $426.0M | ||
| Q3 25 | — | $441.5M | ||
| Q2 25 | — | $456.9M | ||
| Q1 25 | — | $467.3M | ||
| Q4 24 | — | $492.6M | ||
| Q3 24 | — | $502.9M | ||
| Q2 24 | — | $512.7M |
| Q1 26 | $118.4M | — | ||
| Q4 25 | $116.6M | $534.0M | ||
| Q3 25 | $109.3M | $566.8M | ||
| Q2 25 | $105.2M | $552.4M | ||
| Q1 25 | $95.6M | $543.2M | ||
| Q4 24 | $90.6M | $523.5M | ||
| Q3 24 | $87.7M | $566.1M | ||
| Q2 24 | $79.8M | $674.3M |
| Q1 26 | $458.8M | — | ||
| Q4 25 | $460.2M | $1.2B | ||
| Q3 25 | $376.1M | $1.2B | ||
| Q2 25 | $420.7M | $1.2B | ||
| Q1 25 | $370.1M | $1.2B | ||
| Q4 24 | $469.2M | $1.2B | ||
| Q3 24 | $371.9M | $1.3B | ||
| Q2 24 | $302.8M | $1.4B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.80× | ||
| Q3 25 | — | 0.78× | ||
| Q2 25 | — | 0.83× | ||
| Q1 25 | — | 0.86× | ||
| Q4 24 | — | 0.94× | ||
| Q3 24 | — | 0.89× | ||
| Q2 24 | — | 0.76× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $4.4M |
| Free Cash FlowOCF − Capex | — | $3.3M |
| FCF MarginFCF / Revenue | — | 1.2% |
| Capex IntensityCapex / Revenue | — | 0.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $65.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-11.9M | $4.4M | ||
| Q3 25 | $22.2M | $37.8M | ||
| Q2 25 | $-2.2M | $10.6M | ||
| Q1 25 | $8.5M | $17.9M | ||
| Q4 24 | $16.0M | $-4.1M | ||
| Q3 24 | $-3.6M | $28.4M | ||
| Q2 24 | $7.3M | $9.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | $3.3M | ||
| Q3 25 | — | $36.2M | ||
| Q2 25 | — | $8.7M | ||
| Q1 25 | — | $17.6M | ||
| Q4 24 | — | $-4.7M | ||
| Q3 24 | — | $27.7M | ||
| Q2 24 | — | $8.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.2% | ||
| Q3 25 | — | 13.7% | ||
| Q2 25 | — | 3.3% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | — | -1.8% | ||
| Q3 24 | — | 10.9% | ||
| Q2 24 | — | 3.4% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.4% | ||
| Q3 25 | — | 0.6% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.3% |
| Q1 26 | — | — | ||
| Q4 25 | -1.70× | — | ||
| Q3 25 | 4.73× | 3.41× | ||
| Q2 25 | -0.37× | 2.04× | ||
| Q1 25 | 2.30× | 1.01× | ||
| Q4 24 | 2.29× | — | ||
| Q3 24 | -0.66× | — | ||
| Q2 24 | 2.13× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLMB
Segment breakdown not available.
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
